Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
65 /100
HIGH RISK
Score updated Oct 13, 2026

JSPR — Jasper Therapeutics, Inc. Dilution Risk Tracker

Track JSPR dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track JSPR — Get alerts when the score changes →

As of October 13, 2026, Jasper Therapeutics, Inc. (JSPR) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Jasper Therapeutics, Inc. has a market capitalization of $18.97M, 33.27M shares outstanding, 65 institutional holders tracked. Stored dilution-related fields include 675.0K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
95
📊 Float Risk
35
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 53%
🔄 Reverse Split model est. 70%
• 50-day avg $0.93 below $1 exchange minimum
• Only 2 months cash — financial pressure
💰 Capital Raise model 55%
• Critical: only 2.0 months cash remaining
📉 Score Deterioration model 10%
• Score in HIGH risk zone (65/100)
🔔 Track JSPR — Get forecast alerts →

Market Data

Market Cap$18.97M
Shares Outstanding33.27M
Float21.88M
Cash$10.71M
Debt$757.0K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore65/100DilutionWatch score record
Shares Outstanding33.27MVerified float table or market cache
Public Float21.88MVerified float table or market cache
Market Cap$18.97MMarket data cache
Cash Runway2.0 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants675.0KSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 1.

Recent SEC source mix: XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 7.5% shares (2026Q1 vs prior)
65 institutional holders · 21.76M shares
#1 MORGAN STANLEY 4.09M shares
#2 Velan Capital Investment Management LP 2.67M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 2.35M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest6.22M
Days to Cover16.3
% of Float28.4%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-30
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual JSPR Dilution Snapshot

Jasper Therapeutics, Inc. (JSPR) has a DilutionScore of 65/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

JSPR's DilutionScore is currently 65/100 (High risk), with 1 score change tracked over 89 days. The score improved from 57/100 (High risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202665/100HIGH53 days
Jul 16 – Aug 21, 202657/100HIGH36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

JSPR shares outstanding have increased 0.0% from 27.98M (Apr 2026) to 28.00M (Apr 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
Apr 07, 202628.00M21.88M▲ 0.01%
Apr 01, 202627.98M21.88M▲ 0.05%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track JSPR Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment JSPR files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking JSPR — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for JSPR
JSPR FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.